Sofosbuvir-velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial

Wei, L; Lim, SG; Xie, Q; Van, KN; Piratvisuth, T; Huang, Y; Wu, SM; Xu, M; Tang, H; Cheng, J; Le Manh, H; Gao, YH; Mou, ZB; Sobhonslidsuk, A; Dou, XG; Thongsawat, S; Nan, YM; Tan, CK; Ning, Q; Tee, HP; Mao, YM; Stamm, LM; Lu, S; Dvory-Sobol, H; Mo, H

Wei, L (reprint author), Peking Univ, Peoples Hosp, Beijing, Peoples R China.

LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019; 4 (2): 127

Abstract

Background Treatment with combined sofosbuvir and velpatasvir has resulted in high sustained virological response rates in patients chronically infect......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索